In this article, we will discuss the 11 Most Active Small Cap Stocks to Buy.
Investing in small-cap stocks that are active in terms of average trading volume offers a balanced approach to capturing growth while managing some of the inherent risks associated with smaller companies. Small caps are widely known for their ability to deliver outsized returns, as they typically operate earlier in their growth cycle with greater room for revenue and earnings expansion. However, they are also often associated with lower liquidity and higher volatility—challenges that can be meaningfully reduced by focusing on those with consistently high trading volume.
A high three-month average volume is a strong indicator of sustained market participation, ensuring that investors can enter and exit positions efficiently without significantly impacting the stock price. This improved liquidity leads to narrower bid-ask spreads and reduces execution risk, making it easier to transact at fair market value. While small-cap stocks remain more volatile than large-cap peers, higher trading volume helps stabilize price movements by minimizing the impact of isolated large trades.
Importantly, elevated trading volume can also signal growing institutional interest. Since small-cap stocks tend to have limited analyst coverage, increased activity from hedge funds and mutual funds may indicate that the market is beginning to recognize the company’s underlying value. When accompanied by upward price momentum, this can validate the strength of a trend and suggest the potential for a broader re-rating.
At the same time, small-cap companies offer unique growth advantages. Their agility allows them to adapt quickly to emerging technologies and niche opportunities, and they are often attractive acquisition targets for larger firms, which can result in significant shareholder premiums.
By focusing on small-cap stocks with strong trading volume, investors can pursue high-growth opportunities while benefiting from better liquidity, improved price discovery, and more reliable market signals—creating a more disciplined and risk-aware approach to small-cap investing.
With this context in mind, here is a list of the 11 most active small cap stocks to buy.

Our Methodology
We used Yahoo Finance’s “most active stocks” screen to identify stocks with a high 3-month average volume, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. Of these, we picked out small-cap stocks for this article, with market capitalization between $300 million and $2 billion. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
11 Most Active Small Cap Stocks to Buy
11. NextDecade Corporation (NASDAQ:NEXT)
3-month Average Volume: 3.11 million
On March 5, TD Cowen lowered its price target on NextDecade Corporation (NASDAQ:NEXT) to $6 from $7 while maintaining a Hold rating, reflecting updated assumptions around LNG pricing and project economics. The firm noted that while realized margins may be lower than previously expected, the company’s ability to increase contracted capacity and utilize project-level financing provides a constructive pathway forward.
Previously, on February 24, Morgan Stanley reduced its price target on NextDecade Corporation (NASDAQ:NEXT) to $7 from $10 and maintained an Equal Weight rating, citing expectations for a potential oversupply in the global LNG market. While near-term catalysts remain limited as projects are still under development, the long-term structural demand for LNG continues to underpin the investment thesis.
NextDecade Corporation (NASDAQ:NEXT) is a developer of liquefied natural gas export infrastructure, focused on large-scale projects along the U.S. Gulf Coast. Despite near-term uncertainty, the company’s strategic positioning within the global LNG supply chain and its progress toward project execution provide meaningful long-term upside as energy demand continues to evolve.
10. CytomX Therapeutics, Inc. (NASDAQ:CTMX)
3-month Average Volume: 5.91 million
On March 18, CytomX Therapeutics, Inc. (NASDAQ:CTMX) saw Jefferies raise its price target to $16 from $8 while maintaining a Buy rating following encouraging Phase 1 data for its lead asset Varseta-M in late-line metastatic colorectal cancer. The analyst highlighted the therapy’s potential as a differentiated antibody-drug conjugate (ADC), estimating a commercial opportunity exceeding $1 billion in later-line settings, with significantly larger upside as the drug advances into earlier treatment lines.
The same day, Guggenheim also raised its price target on CytomX Therapeutics, Inc. (NASDAQ:CTMX) to $15 from $10, reiterating a Buy rating. The firm noted that updated clinical data at both tested dose levels materially outperformed current standards of care, prompting an increase in its estimated probability of success to 60% from 30%. This meaningful improvement in clinical confidence, combined with strong efficacy signals, reinforces the asset’s potential to become a best-in-class therapy.
CytomX Therapeutics, Inc. (NASDAQ:CTMX) is a clinical-stage oncology-focused biopharmaceutical company developing conditionally activated PROBODY® therapeutics designed to target tumors while limiting systemic toxicity. With increasingly compelling clinical data and rising analyst conviction, the company appears well-positioned to unlock significant value as its pipeline advances, supporting a favorable risk-reward profile for investors seeking exposure to innovative oncology assets.
9. The Wendy’s Company (NASDAQ:WEN)
3-month Average Volume: 8.20 million
On March 4, The Wendy’s Company (NASDAQ:WEN) announced new franchise agreements to expand its footprint in Mexico by more than 60 locations, partnering with regional operators to drive growth in key urban markets. The initiative strengthens Wendy’s international expansion strategy and enhances its ability to penetrate high-growth regions, supporting long-term revenue diversification.
Previously, on February 23, JPMorgan lowered its price target on The Wendy’s Company (NASDAQ:WEN) to $7 from $9 while maintaining a Neutral rating, citing ongoing operational challenges and capital structure considerations. However, the firm also emphasized that management is focused on stabilizing the business, suggesting that current headwinds are being actively addressed.
The Wendy’s Company (NASDAQ:WEN) operates and franchises quick-service restaurants globally, with a strong presence in both domestic and international markets. As the company accelerates international expansion and leverages franchise partnerships to drive capital-efficient growth, it offers potential upside through improved scale, brand penetration, and operational execution.
8. Ur-Energy Inc. (NYSEAMERICAN:URG)
3-month Average Volume: 8.88 million
On March 12, Northland Securities lowered its price target on Ur-Energy Inc. (NYSEAMERICAN:URG) to $1.85 from $2.15 while maintaining an Outperform rating, citing higher operating costs at the Lost Creek project and delays in the Shirley Basin startup due to regulatory factors. Despite these adjustments, the firm continues to view the company favorably, reflecting confidence in its long-term production growth and asset base.
The same day, H.C. Wainwright reduced its price target on Ur-Energy Inc. (NYSEAMERICAN:URG) to $2.30 from $2.60 while reiterating a Buy rating, attributing the revision primarily to recent equity dilution. Importantly, operational performance remains strong, with 2025 ending inventory up 21% year-over-year, production volumes increasing significantly, and profit per pound improving by more than $12, indicating enhanced pricing power and cost efficiency.
Ur-Energy Inc. (NYSEAMERICAN:URG) is a uranium mining and development company engaged in the exploration, recovery, and processing of uranium resources. With improving operational metrics, rising inventory levels, and continued exposure to strengthening uranium market fundamentals, the company appears positioned to benefit from growing global demand for nuclear energy, supporting its investment appeal.
7. POET Technologies Inc. (NASDAQ:POET)
3-month Average Volume: 8.89 million
On March 17, POET Technologies Inc. (NASDAQ:POET) announced a joint development initiative with Lessengers to create a 1.6T 2xDR4 optical transceiver module tailored for next-generation AI clusters and hyperscale data center environments. The solution integrates POET’s optical engines—built on its Optical Interposer platform—with Lessengers’ Direct Optical Wiring technology, enabling a compact, high-density architecture for advanced optical interconnects. The module is designed to integrate lasers, modulators, photodiodes, and passive components into a single photonic platform, while improving routing efficiency and simplifying packaging. With samples expected in Q2 2026, the collaboration positions the company to capitalize on the growing demand for high-bandwidth connectivity driven by AI infrastructure expansion.
On March 16, POET Technologies Inc. (NASDAQ:POET) also announced a strategic partnership with LITEON Technology to co-develop next-generation optical communication modules leveraging its Optical Interposer platform. The collaboration aims to integrate optical components and electronics into compact, thermally optimized modules suitable for co-packaged optics and AI-driven systems. Development is set to begin immediately, with prototypes expected by late 2026 and volume production targeted for 2027. Together, these partnerships reinforce POET’s positioning within the rapidly evolving optical networking ecosystem, enhancing its long-term growth outlook.
POET Technologies Inc. (NASDAQ:POET) designs and develops high-speed optical engines, light sources, and custom optical modules for AI systems and hyperscale data centers. Its patented Optical Interposer platform integrates photonic and electronic devices at chip scale using established semiconductor manufacturing techniques.
6. HIVE Digital Technologies Ltd. (NASDAQ:HIVE)
3-month Average Volume: 10.58 million
On March 18, HIVE Digital Technologies Ltd. (NASDAQ:HIVE) announced that its BUZZ AI Cloud platform in Paraguay is now operational, with live GPU compute nodes actively supporting workloads from a research team at Columbia University. The deployment represents the first operational cluster under the company’s broader strategy to layer AI and high-performance computing capabilities onto its renewable energy infrastructure. By demonstrating real-world use cases, the initiative serves as a proof of concept for cross-border AI compute solutions and highlights the company’s ability to monetize its infrastructure beyond cryptocurrency mining.
On March 16, HIVE Digital Technologies Ltd. (NASDAQ:HIVE) announced a fourfold expansion of its liquid-cooled AI data center capacity in Canada, increasing total capacity from 4 megawatts to 16.6 megawatts across multiple provinces. The expansion includes a new facility in British Columbia and supports the deployment of over 4,000 next-generation GPUs across its network. This rapid scaling of AI compute capacity accelerates the company’s transition toward high-performance computing services, positioning it to benefit from surging demand for AI infrastructure.
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) operates sustainable data centers powered by renewable energy, supporting both Bitcoin mining and AI-driven high-performance computing workloads. As the company pivots toward AI infrastructure while leveraging its green energy advantage, it is well-positioned to capture growth in both digital assets and AI computing markets, enhancing its long-term upside potential.
While we acknowledge the potential of HIVE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HIVE and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Most Active Small Cap Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.





